Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB AS Baldwin The Journal of clinical investigation 107 (3), 241-246, 2001 | 1796 | 2001 |
Series introduction: the transcription factor NF-κB and human disease AS Baldwin The Journal of clinical investigation 107 (1), 3-6, 2001 | 1547 | 2001 |
Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB CY Wang, JC Cusack, R Liu, AS Baldwin Nature medicine 5 (4), 412-417, 1999 | 1336 | 1999 |
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. AA Beg, AS Baldwin Jr Genes & development 7 (11), 2064-2070, 1993 | 1110 | 1993 |
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38 LV Madrid, MW Mayo, JY Reuther, AS Baldwin Journal of Biological Chemistry 276 (22), 18934-18940, 2001 | 994 | 2001 |
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. AA Beg, SM Ruben, RI Scheinman, S Haskill, CA Rosen, ASJ Baldwin Genes & development 6 (10), 1899-1913, 1992 | 990 | 1992 |
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies RZ Orlowski, TE Stinchcombe, BS Mitchell, TC Shea, AS Baldwin, S Stahl, ... Journal of Clinical Oncology 20 (22), 4420-4427, 2002 | 952 | 2002 |
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression DS Basseres, AS Baldwin Oncogene 25 (51), 6817-6830, 2006 | 857 | 2006 |
Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA H Singh, JH LeBowitz, AS Baldwin, PA Sharp Cell 52 (3), 415-423, 1988 | 782 | 1988 |
NF-κB as a therapeutic target in cancer RZ Orlowski, AS Baldwin Trends in molecular medicine 8 (8), 385-389, 2002 | 781 | 2002 |
Human CCAAT-binding proteins have heterologous subunits LA Chodosh, AS Baldwin, RW Carthew, PA Sharp Cell 53 (1), 11-24, 1988 | 776 | 1988 |
Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding AJG Schottelius, MW Mayo, RB Sartor, AS Baldwin Journal of Biological Chemistry 274 (45), 31868-31874, 1999 | 749 | 1999 |
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK HC Dan, MJ Cooper, PC Cogswell, JA Duncan, JPY Ting, AS Baldwin Genes & development 22 (11), 1490-1500, 2008 | 727 | 2008 |
A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression V Anest, JL Hanson, PC Cogswell, KA Steinbrecher, BD Strahl, ... Nature 423 (6940), 659-663, 2003 | 702 | 2003 |
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance MW Mayo, AS Baldwin Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1470 (2), M55-M62, 2000 | 629 | 2000 |
Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 PC Cogswell, DC Guttridge, WK Funkhouser, AS Baldwin Oncogene 19 (9), 1123-1131, 2000 | 623 | 2000 |
Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II D Wang, SD Westerheide, JL Hanson, AS Baldwin Journal of Biological Chemistry 275 (42), 32592-32597, 2000 | 590 | 2000 |
NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint AV Miagkov, DV Kovalenko, CE Brown, JR Didsbury, JP Cogswell, ... Proceedings of the National Academy of Sciences 95 (23), 13859-13864, 1998 | 586 | 1998 |
NF-κB and IKK as therapeutic targets in cancer HJ Kim, N Hawke, AS Baldwin Cell Death & Differentiation 13 (5), 738-747, 2006 | 543 | 2006 |
Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy S Acharyya, SA Villalta, N Bakkar, T Bupha-Intr, PML Janssen, ... The Journal of clinical investigation 117 (4), 889-901, 2007 | 537 | 2007 |